Eric Hahnen

17.6k total citations · 1 hit paper
86 papers, 5.4k citations indexed

About

Eric Hahnen is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Eric Hahnen has authored 86 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 41 papers in Genetics and 25 papers in Genetics. Recurrent topics in Eric Hahnen's work include BRCA gene mutations in cancer (32 papers), Neurogenetic and Muscular Disorders Research (22 papers) and Cancer Genomics and Diagnostics (19 papers). Eric Hahnen is often cited by papers focused on BRCA gene mutations in cancer (32 papers), Neurogenetic and Muscular Disorders Research (22 papers) and Cancer Genomics and Diagnostics (19 papers). Eric Hahnen collaborates with scholars based in Germany, United States and Netherlands. Eric Hahnen's co-authors include Brunhilde Wirth, Elliot J. Androphy, Christian L. Lorson, Sabine Rudnik‐Schöneborn, Klaus Zerres, Ingmar Blümcke, Ilker Y. Eyüpoglu, Jan Hauke, Lars Brichta and Jutta Schönling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Genetics.

In The Last Decade

Eric Hahnen

78 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

1999 1.2k citations Eric Hahnen, Brunhilde Wirth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Hahnen Germany	34	4.1k	3.3k	1.2k	685	412	86	5.4k
Niketa Patel United States	28	2.0k 0.5×	1.2k 0.4×	557 0.5×	143 0.2×	438 1.1×	70	3.5k
J. Fred Hess United States	26	1.6k 0.4×	2.0k 0.6×	207 0.2×	361 0.5×	936 2.3×	41	4.0k
Ronald D. Cohn United States	24	3.4k 0.8×	376 0.1×	466 0.4×	523 0.8×	610 1.5×	38	4.4k
Jong Wook Chang South Korea	31	1.4k 0.3×	1.1k 0.3×	413 0.3×	133 0.2×	330 0.8×	78	2.8k
Haeyoung Suh‐Kim South Korea	28	1.1k 0.3×	706 0.2×	364 0.3×	261 0.4×	607 1.5×	78	2.2k
Xiaobing Yu United States	23	2.2k 0.5×	377 0.1×	356 0.3×	402 0.6×	242 0.6×	43	3.7k
Patrick Aubourg France	31	2.0k 0.5×	312 0.1×	415 0.3×	420 0.6×	516 1.3×	57	3.4k
Claudio Bruno Italy	37	3.3k 0.8×	678 0.2×	562 0.5×	426 0.6×	483 1.2×	146	4.6k
Patrick Edery France	33	2.4k 0.6×	221 0.1×	1.2k 1.0×	1.6k 2.3×	304 0.7×	117	4.5k
Christopher R. Pierson United States	31	1.1k 0.3×	373 0.1×	415 0.3×	440 0.6×	273 0.7×	103	2.9k

Countries citing papers authored by Eric Hahnen

Since Specialization

Citations

This map shows the geographic impact of Eric Hahnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Hahnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Hahnen more than expected).

Fields of papers citing papers by Eric Hahnen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Hahnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Hahnen. The network helps show where Eric Hahnen may publish in the future.

Co-authorship network of co-authors of Eric Hahnen

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Hahnen. A scholar is included among the top collaborators of Eric Hahnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Hahnen. Eric Hahnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herold, N, Corinna Ernst, Britta Blümcke, et al.. (2024). Implementing mainstream genetic counseling within the area‐wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC‐HBOC): Satisfaction of primary care providers with the provided state‐of‐the‐art training by the Cologne Center. Journal of Genetic Counseling. 33(1). 206–215. 1 indexed citations

Heitz, Florian, Christian Marth, Stéphanie Henry, et al.. (2023). AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial. International Journal of Gynecological Cancer. 33(12). 1966–1969. 11 indexed citations

Ataseven, Beyhan, Chiara Cassani, Marco D’Indinosante, et al.. (2022). Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients. International Journal of Gynecological Cancer. 33(2). 257–262. 3 indexed citations

Weber‐Lassalle, Konstantin, Philipp Harter, Jan Hauke, et al.. (2018). Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis. Human Mutation. 39(12). 2040–2046. 17 indexed citations

Hahnen, Eric, Jan Hauke, Christoph Engel, et al.. (2017). Germline Mutations in Triple-Negative Breast Cancer. Breast Care. 12(1). 15–19. 42 indexed citations

Meindl, A, Juliane Ramser, Jan Hauke, & Eric Hahnen. (2015). Genetic aspects of hereditary breast and ovarian cancer: options and limits. Kölner Universitäts PublikationsServer (Universität zu Köln). 1 indexed citations

Meindl, A, Kerstin Rhiem, Christoph Engel, et al.. (2013). Clinical course and genetics of hereditary breast and ovarian cancer. mediaTUM (Technical University of Munich).

Fourcade, Stéphane, Montserrat Ruíz, Cristina Guilera, et al.. (2010). Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Human Molecular Genetics. 19(10). 2005–2014. 76 indexed citations

Rießland, Markus, Anja Förster, Jan Hauke, et al.. (2010). SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Human Molecular Genetics. 19(8). 1492–1506. 177 indexed citations

10.

Engelhorn, Tobias, Nicolai Savaskan, Marc Schwarz, et al.. (2009). Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Science. 100(10). 1856–1862. 74 indexed citations

11.

Kobow, Katja, Michelle A.T. Hildebrandt, Jan Hauke, et al.. (2009). Increased Reelin Promoter Methylation Is Associated With Granule Cell Dispersion in Human Temporal Lobe Epilepsy. Journal of Neuropathology & Experimental Neurology. 68(4). 356–364. 131 indexed citations

12.

Hauke, Jan, Markus Rießland, Sebastian Lunke, et al.. (2008). Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Human Molecular Genetics. 18(2). 304–317. 111 indexed citations

13.

Wirth, Brunhilde, Markus Rießland, & Eric Hahnen. (2007). Drug discovery for spinal muscular atrophy. Expert Opinion on Drug Discovery. 2(4). 437–451. 3 indexed citations

14.

Siebzehnrübl, Florian A., et al.. (2007). Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Experimental Brain Research. 176(4). 672–678. 84 indexed citations

15.

Rießland, Markus, Lars Brichta, Eric Hahnen, & Brunhilde Wirth. (2006). The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Human Genetics. 120(1). 101–110. 104 indexed citations

16.

Wirth, Brunhilde, Lars Brichta, & Eric Hahnen. (2006). Spinal Muscular Atrophy: From Gene to Therapy. Seminars in Pediatric Neurology. 13(2). 121–131. 104 indexed citations

17.

Hölsken, Annett, Ilker Y. Eyüpoglu, Christian Tränkle, et al.. (2006). Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases. Acta Neuropathologica. 112(2). 205–215. 14 indexed citations

18.

Hahnen, Eric, Ilker Y. Eyüpoglu, Lars Brichta, et al.. (2006). In vitro and ex vivo evaluation of second‐generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. Journal of Neurochemistry. 98(1). 193–202. 126 indexed citations

19.

Eyüpoglu, Ilker Y., Eric Hahnen, Florian A. Siebzehnrübl, et al.. (2005). Malignant glioma—induced neuronal cell death in an organotypic glioma invasion model. Journal of neurosurgery. 102(4). 738–744. 37 indexed citations

20.

Hahnen, Eric, et al.. (1997). Missense Mutations in Exon 6 of the Survival Motor Neuron Gene in Patients with Spinal Muscular Atrophy (SMA). Human Molecular Genetics. 6(5). 821–825. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact